S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
BATS:VFVA

Vanguard U.S. Value Factor ETF ETF Shares Stock Forecast, Price & News

$83.59
-1.03 (-1.22 %)
(As of 01/15/2021 12:00 AM ET)
Add
Today's Range
$82.93
Now: $83.59
$84.47
50-Day Range
$73.95
MA: $78.37
$84.62
52-Week Range N/A
Volume16,206 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Geographic Exposure of VFVA

Currency Exposure of VFVA

Sector Exposure of VFVA

Industry Exposure of VFVA


Basic Details

Issuer Vanguard
Fund NameVanguard U.S. Value Factor
Tax ClassificationRegulated Investment Company
SymbolBATS:VFVA
Inception Date2/13/2018
Fund ManagerAntonio Picca, Liqian Ren
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNot Applicable
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$127.65 million
Average Daily Volume$11,472.50
Discount/Premium-0.01%

ETF Expenses

Management Fee0.04%
Other Expenses0.09%
Total Expenses0.13%
Fee Waiver0.00%
Net Expenses0.13%

Administrator, Advisor and Custodian

AdministratorThe Vanguard Group, Inc.
AdvisorThe Vanguard Group, Inc.
CustodianThe Bank of New York Mellon Corporation
DistributorVanguard Marketing Corporation
Transfer AgentThe Vanguard Group, Inc.
Trustee
Lead Market MakerJane Street
$83.59
-1.03 (-1.22 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VFVA News and Ratings via Email

Sign-up to receive the latest news and ratings for VFVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vanguard U.S. Value Factor ETF ETF Shares (BATS:VFVA) Frequently Asked Questions

How has Vanguard U.S. Value Factor ETF ETF Shares' stock been impacted by COVID-19?

Vanguard U.S. Value Factor ETF ETF Shares' stock was trading at $53.6650 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, VFVA shares have increased by 55.8% and is now trading at $83.5853.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Vanguard U.S. Value Factor ETF ETF Shares?

Wall Street analysts have given Vanguard U.S. Value Factor ETF ETF Shares a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Vanguard U.S. Value Factor ETF ETF Shares wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What other stocks do shareholders of Vanguard U.S. Value Factor ETF ETF Shares own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vanguard U.S. Value Factor ETF ETF Shares investors own include Annaly Capital Management (NLY), Resideo Technologies (REZI), Tradeweb Markets (TW), Vanguard Dividend Appreciation Index Fund ETF Shares (VIG), Gilead Sciences (GILD), Lululemon Athletica (LULU), Merck & Co., Inc. (MRK), Peloton Interactive (PTON), Synopsys (SNPS) and Tencent (TCEHY).

What is Vanguard U.S. Value Factor ETF ETF Shares' stock symbol?

Vanguard U.S. Value Factor ETF ETF Shares trades on the BATS under the ticker symbol "VFVA."

How do I buy shares of Vanguard U.S. Value Factor ETF ETF Shares?

Shares of VFVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vanguard U.S. Value Factor ETF ETF Shares' stock price today?

One share of VFVA stock can currently be purchased for approximately $83.59.

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.